CVS Health Corp.
CVSLast close · Oct 16, 202692.36−0.22 (−0.24%)
Market cap$118.1B
Of the 85 managers this site tracks, 12 held CVS Health (CVS) at the end of Q3 2026, their latest 13Fs. The largest position by value was Dodge & Cox's, $5.2B; Christopher Davis's ($1.2B) and Richard Pzena's ($1.2B) follow. No Schedule 13D or 13G is on file for CVS from the activists and large holders the site follows.
Superinvestors holding CVS
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Dodge & Cox | Dodge & Cox | Q2 2026 | 50M | $5.2B |
| Christopher Davis | Davis Selected Advisers | Q2 2026 | 12M | $1.2B |
| Richard Pzena | Pzena Investment Management LLC | Q2 2026 | 12M | $1.2B |
| Viking Global | Viking Global Investors LP | Q2 2026 | 4M | $379.0M |
| Prem Watsa | Fairfax Financial Holdings Ltd | Q2 2026 | 3M | $280.5M |
| Samantha McLemore | Patient Capital Management, LLC | Q2 2026 | 1M | $127.8M |
| John Rogers | Ariel Investments, LLC | Q2 2026 | 730,110 | $75.5M |
| Bridgewater | Bridgewater Associates, LP | Q2 2026 | 440,972 | $45.6M |
| Bill Nygren | Harris Associates L P | Q2 2026 | 335,817 | $34.7M |
| Hillman Capital | Hillman Capital Management, Inc. | Q2 2026 | 55,475 | $5.7M |
| Robert Olstein | Olstein Capital Management, L.P. | Q1 2026 | 50,000 | $3.6M |
| David Katz | Matrix Asset Advisors Inc | Q3 2026 | 6,175 | $529,136 |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.